Letters to the Editor Low Rates of Side Effects in Paclitaxel Chemotherapy for Kaposi Sarcoma and Feasibility of Treatment in Outpatient ART Clinic Settings in Malawi

J Acquir Immune Defic Syndr. 2024 May 1;96(1):e1-e2. doi: 10.1097/QAI.0000000000003393. Epub 2024 Apr 10.

Authors

Ethel Rambiki¹, Kelvin Rambiki¹, Jennipher Khalani¹, Jacquiline Huwa¹, Claudia Wallrauch¹, Tom Heller^{1

2}, Matthew Painschab^{3

4}

Affiliations

¹ Medical Department, Lighthouse Trust, Kamuzu Central Hospital, Lilongwe, Malawi.
² Medical Department, University of Washington, International Training and Education Center for Health, Lilongwe, Malawi.
³ Adult Oncology Division, UNC Project Malawi, Lilongwe, Malawi.
⁴ Lineberger Comprehensive Cancer Center, Chapel Hill, NC.

No abstract available

MeSH terms

Feasibility Studies
HIV Infections* / drug therapy
Humans
Malawi
Outpatients
Paclitaxel / adverse effects
Sarcoma, Kaposi* / drug therapy

Substances

Paclitaxel

Grants and funding